Predictors of Development of Diabetes Mellitus in Patients With Coronary Artery Disease Taking Antihypertensive Medications (Findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])
- 1 October 2006
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 98 (7), 890-894
- https://doi.org/10.1016/j.amjcard.2006.04.030
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Drug Dose Model for Predicting Clinical Outcomes in Hypertensive Coronary Disease PatientsThe Journal of Clinical Hypertension, 2005
- Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent?Diabetes Care, 2005
- Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose ToleranceDiabetes Care, 2005
- Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril StudyHypertension, 2004
- Cardiovascular Therapies and Risk for Development of DiabetesJournal of the American College of Cardiology, 2004
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery DiseaseJama-Journal Of The American Medical Association, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertensionJournal of the American College of Cardiology, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of Internal Medicine, 1997